1573425 - ENFORTumab vedotina 30 mg Pó conc sol inj Fr IV

ID 12206070 · Portal BASE
Price
Base Price
€5,400 .00
Effective Price
€5,400 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33000000
Location
Portugal, Porto, Porto
Bidder Count
—
Winner
ASTELLAS FARMA LDA
NIF 502540249
Company
Dates
Publication
29 Dec 2025
Celebration
30 Sep 2025
Contracting Entity
Instituto Português de Oncologia do Porto Francisco Gentil, E. P. E.
NIF 506362299
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 40 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
29 Dec 2025
Signing Date
30 Sep 2025
Days Late
90
Rule
A2/A3 late publication: 90 days after signing (threshold: 10)
Detected 2026-03-06